FDA 483 - University of Iowa RDRC - June 27, 2025

An FDA inspection of the University of Iowa RDRC in Iowa City, IA, revealed one observation. The Radioactive Drug Research Committee failed to meet quarterly as required, specifically missing meetings in the first and fourth quarters of 2023 while research activity was ongoing. This indicates a lapse in oversight for approved RDRC studies.